Highly Leveraged Dow Jones Biotechnology Companies

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Total Debt
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Total DebtEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
67.14 B
 0.20 
 1.39 
 0.28 
2AMGN Amgen Inc
60.1 B
 0.20 
 1.50 
 0.30 
3BIIB Biogen Inc
6.63 B
(0.06)
 1.76 
(0.11)
4GILD Gilead Sciences
3.11 B
 0.22 
 1.56 
 0.34 
5CRL Charles River Laboratories
2.72 B
(0.10)
 2.35 
(0.24)
6REGN Regeneron Pharmaceuticals
2.7 B
(0.07)
 2.06 
(0.14)
7ILMN Illumina
2.54 B
(0.29)
 2.74 
(0.80)
8VRTX Vertex Pharmaceuticals
1.75 B
 0.24 
 1.50 
 0.36 
9HALO Halozyme Therapeutics
1.51 B
 0.33 
 1.46 
 0.48 
10IONS Ionis Pharmaceuticals
1.41 B
(0.06)
 2.62 
(0.15)
11ALNY Alnylam Pharmaceuticals
1.3 B
 0.08 
 3.02 
 0.26 
12BMRN Biomarin Pharmaceutical
602.71 M
 0.10 
 1.64 
 0.16 
13OPK Opko Health
528.54 M
 0.10 
 2.61 
 0.27 
14NBIX Neurocrine Biosciences
455.1 M
(0.10)
 2.82 
(0.27)
15TECH Bio Techne Corp
419.54 M
(0.14)
 2.17 
(0.31)
16BLUE Bluebird bio
330.33 M
(0.12)
 6.78 
(0.79)
17MYGN Myriad Genetics
326.5 M
(0.17)
 3.73 
(0.63)
18UTHR United Therapeutics
300 M
(0.10)
 2.30 
(0.22)
19NVAX Novavax
230.42 M
(0.02)
 4.69 
(0.10)
20ALKS Alkermes Plc
75.54 M
 0.13 
 1.89 
 0.25 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY